Article
Novel use of imatinib to treat mandibular fibrous dysplasia in Noonan's syndrome
2023-01-28
Abstract excerpt
Fibrous dysplasia of the mandible typically begins during toddler years and culminates during puberty. These lesions may cause jaw disfigurement and may not be amendable to surgery. Imatinib successfully has treated cherubism associated with SH3BP2 mutations, but similar lesions can present in other conditions such as Noonan syndrome. We report diagnosis of Noonan syndrome caused by a PTPN11 activating mutation...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- da2b6a04-1002-5a7f-8b40-5135c95dc10a
- DOI
- 10.22541/au.167492166.61754838/v1
